PT2470213E - Composição para tratamento de distúrbios ou doenças neurodegenerativas e método e utilização compreendendo levedura eletromageticamente irradiada - Google Patents

Composição para tratamento de distúrbios ou doenças neurodegenerativas e método e utilização compreendendo levedura eletromageticamente irradiada Download PDF

Info

Publication number
PT2470213E
PT2470213E PT107496358T PT10749635T PT2470213E PT 2470213 E PT2470213 E PT 2470213E PT 107496358 T PT107496358 T PT 107496358T PT 10749635 T PT10749635 T PT 10749635T PT 2470213 E PT2470213 E PT 2470213E
Authority
PT
Portugal
Prior art keywords
disorders
treatment
composition
neurodegenerative diseases
electromagnetically irradiated
Prior art date
Application number
PT107496358T
Other languages
English (en)
Inventor
Kent Toernqvist
Maria Sibileva
Peter Ek
Anders Fredriksson
Trevor Archer
Tatiana Blomqvist
Dmitry Mudrik
Natalia Golant
Ludmila Balakireva
Original Assignee
Milmed Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Milmed Ab filed Critical Milmed Ab
Publication of PT2470213E publication Critical patent/PT2470213E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Mycology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Endocrinology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT107496358T 2009-08-26 2010-08-26 Composição para tratamento de distúrbios ou doenças neurodegenerativas e método e utilização compreendendo levedura eletromageticamente irradiada PT2470213E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0950613 2009-08-26

Publications (1)

Publication Number Publication Date
PT2470213E true PT2470213E (pt) 2014-01-20

Family

ID=43243750

Family Applications (1)

Application Number Title Priority Date Filing Date
PT107496358T PT2470213E (pt) 2009-08-26 2010-08-26 Composição para tratamento de distúrbios ou doenças neurodegenerativas e método e utilização compreendendo levedura eletromageticamente irradiada

Country Status (10)

Country Link
US (2) US9320768B2 (pt)
EP (1) EP2470213B1 (pt)
JP (2) JP5905823B2 (pt)
CN (1) CN102481368B (pt)
DK (1) DK2470213T3 (pt)
ES (1) ES2441974T3 (pt)
PL (1) PL2470213T3 (pt)
PT (1) PT2470213E (pt)
SI (1) SI2470213T1 (pt)
WO (1) WO2011023769A1 (pt)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10398729B2 (en) * 2012-02-14 2019-09-03 Kenneth O. Russell Method for treating Alzheimer's disease
PL2470213T3 (pl) * 2009-08-26 2014-05-30 Milmed Ab Kompozycje do leczenia chorób lub zaburzeń neurodegeneracyjnych, sposób i zastosowanie obejmujące elektromagnetycznie napromienione drożdże
ES2964972T3 (es) * 2016-07-25 2024-04-10 Sarah Kathryn Patch Sistema de verificación de alcance de haz de radiación usando mediciones sónicas
SE1951142A1 (en) * 2019-10-07 2020-11-24 Milmed Unico Ab Yeast for the treatment of allergy

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1564189A1 (ru) * 1988-07-05 1990-05-15 Киевский Технологический Институт Пищевой Промышленности Способ выращивани дрожжей
WO2002062982A1 (fr) 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications
WO2002062983A1 (fr) 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications
WO2002062984A1 (fr) 2001-02-08 2002-08-15 Six Forest Bio-Science Institute Limited Levure faisant preuve d'une activite immunoregulatrice du lymphocyte k, son procede de production et ses applications
US20040005336A1 (en) * 2002-06-28 2004-01-08 Cheung Ling Yuk Dietary supplements for regulating the central nervous system
US20040001859A1 (en) 2002-06-28 2004-01-01 Cheung Ling Yuk Anti-aging dietary supplements
EA004756B1 (ru) * 2002-10-25 2004-08-26 Сергей Дмитриевич Огурцов Способ воздействия на биологический объект и устройство для осуществления этого способа
AU2005227420B2 (en) * 2005-10-14 2013-05-09 Alltech, Inc. Method and compositions for altering cell function
PL2470213T3 (pl) * 2009-08-26 2014-05-30 Milmed Ab Kompozycje do leczenia chorób lub zaburzeń neurodegeneracyjnych, sposób i zastosowanie obejmujące elektromagnetycznie napromienione drożdże

Also Published As

Publication number Publication date
JP2013503138A (ja) 2013-01-31
US9320768B2 (en) 2016-04-26
PL2470213T3 (pl) 2014-05-30
US20120190095A1 (en) 2012-07-26
JP2016094460A (ja) 2016-05-26
SI2470213T1 (sl) 2014-04-30
JP5905823B2 (ja) 2016-04-20
CN102481368A (zh) 2012-05-30
ES2441974T3 (es) 2014-02-07
CN102481368B (zh) 2014-01-29
WO2011023769A1 (en) 2011-03-03
EP2470213A1 (en) 2012-07-04
JP6139650B2 (ja) 2017-05-31
DK2470213T3 (da) 2014-01-20
EP2470213B1 (en) 2013-10-16
US20160220621A1 (en) 2016-08-04

Similar Documents

Publication Publication Date Title
EP2432476A4 (en) METHOD FOR THE TREATMENT OR PREVENTION OF EYE DISEASES
EP2467116A4 (en) METHOD AND APPARATUS FOR NON-INVASIVE AESTHETIC TREATMENT OF SKIN AND HYPODERM
EP2621420A4 (en) CORNEAL TREATMENT SYSTEM AND METHOD
IL216967A0 (en) 17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
IL207687A0 (en) Method of treating ocular diseases by gene therapy
EP2401561A4 (en) DEVICE AND METHOD FOR TREATMENT BY CRYOTHERAPY
ZA201203281B (en) Pharmaceutical combinations, pharmaceutical compositions, medicament and method for the treatment of animals
HK1176870A1 (zh) 疾病的治療方法
ZA201109449B (en) Methods and products for treatment of diseases
EP2274411A4 (en) XANTHOHUMOL COMPOSITIONS AND METHODS FOR TREATING SKIN DISEASES OR CONDITIONS
HK1149545A1 (en) Compositions and methods for treating ophthalmic diseases
SG10201405392RA (en) Method of treatment of neurodegenerative or neuro-muscular degenerative diseases andtherapeutic agent to treat the same
EP2558104A4 (en) METHOD AND OPHTHALMIC COMPOSITION FOR TREATING RETINAL DISEASE
PL2470213T3 (pl) Kompozycje do leczenia chorób lub zaburzeń neurodegeneracyjnych, sposób i zastosowanie obejmujące elektromagnetycznie napromienione drożdże
EP2723325A4 (en) NEW FORMULATIONS AND METHODS FOR TREATING DERMATOLOGICAL DISORDERS OR DISEASES
EP2654434A4 (en) METHOD FOR TREATING TISSUE DISEASES, TROUBLES AND INJURIES
WO2011062762A3 (en) Angiogenin and variants thereof for treatment of neurodegenerative diseases
AP2011006014A0 (en) Method and device for treatment of human excrement.
EP2462131A4 (en) COMPOSITIONS AND METHODS FOR TREATING DISEASES ASSOCIATED WITH BETA-AMYLOID
IL213399A0 (en) Method of treatment of diseases using hoodia extracts
GB0803515D0 (en) Medicament and method of treatment
AU2009904136A0 (en) Method for treatment and diagnosis